134 related articles for article (PubMed ID: 7940682)
1. A prospective, randomized comparison of cyclophosphamide and azathioprine for early rejection prophylaxis after cardiac transplantation. Decreased sensitization to OKT3.
Taylor DO; Bristow MR; O'Connell JB; Ensley RD; Olsen SL; Hammond EH; Wagoner LE; Renlund DG
Transplantation; 1994 Sep; 58(6):645-9. PubMed ID: 7940682
[TBL] [Abstract][Full Text] [Related]
2. Cyclophosphamide in cardiac transplant recipients with frequent rejection: a six-year retrospective review.
Wagoner LE; Taylor DO; Olsen SL; Bristow MR; O'Connell JB; Hammond EH; Lappe DL; Renlund DG
Clin Transplant; 1996 Oct; 10(5):437-43. PubMed ID: 8930458
[TBL] [Abstract][Full Text] [Related]
3. A prospective comparison of murine monoclonal CD-3 (OKT3) antibody-based and equine antithymocyte globulin-based rejection prophylaxis in cardiac transplantation. Decreased rejection and less corticosteroid use with OKT3.
Renlund DG; O'Connell JB; Gilbert EM; Hammond ME; Burton NA; Jones KW; Karwande SV; Doty DB; Menlove RL; Herrick CM
Transplantation; 1989 Apr; 47(4):599-605. PubMed ID: 2523099
[TBL] [Abstract][Full Text] [Related]
4. Immunologic monitoring of OKT3 induction therapy in cardiac allograft recipients.
Toyoda M; Galfayan K; Wachs K; Czer L; Jordan SC
Clin Transplant; 1995 Dec; 9(6):472-80. PubMed ID: 8645891
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate for rejection prophylaxis after heart transplantation.
Taylor DO; Olsen SL; Ensley RD; Renlund DG
J Heart Lung Transplant; 1995; 14(5):950-4. PubMed ID: 8800732
[TBL] [Abstract][Full Text] [Related]
6. A randomized prospective trial of prophylactic immunosuppression with ATG-fresenius versus OKT3 after renal transplantation.
Bock HA; Gallati H; Zürcher RM; Bachofen M; Mihatsch MJ; Landmann J; Thiel G
Transplantation; 1995 Mar; 59(6):830-40. PubMed ID: 7701577
[TBL] [Abstract][Full Text] [Related]
7. Sensitization to OKT3 monoclonal antibody in heart transplantation: correlation with early allograft loss.
O'Connell JB; Renlund DG; Hammond EH; Wittwer CT; Yowell RL; DeWitt CW; Jones KW; Gay WA; Menlove RL; Bristow MR
J Heart Lung Transplant; 1991; 10(2):217-21; discussion 221-2. PubMed ID: 1903303
[TBL] [Abstract][Full Text] [Related]
8. The duration of administration of monoclonal antibody OKT3 for induction immunosuppression after heart transplantation.
Aleksic I; Freimark D; Blanche C; Czer LS; Dalichau H; Valenza M; Takkenberg JJ; Trento A
Thorac Cardiovasc Surg; 1997 Aug; 45(4):190-5. PubMed ID: 9323821
[TBL] [Abstract][Full Text] [Related]
9. A prospective randomized controlled trial of initial immunosuppression with ALG versus OKT3 in recipients of cardiac allografts.
Menkis AH; Powell AM; Novick RJ; McKenzie FN; Kostuk WJ; Pflugfelder PW; Brown JE; Rochon J; Chow LH; Stiller C
J Heart Lung Transplant; 1992; 11(3 Pt 1):569-76. PubMed ID: 1610866
[TBL] [Abstract][Full Text] [Related]
10. Prospective randomized trial of OKT3- versus horse antithymocyte globulin-based immunosuppressive prophylaxis in heart transplantation.
Costanzo-Nordin MR; O'Sullivan EJ; Johnson MR; Winters GL; Pifarre R; Radvany R; Zucker MJ; Scanlon PJ; Robinson JA
J Heart Transplant; 1990; 9(3 Pt 2):306-15. PubMed ID: 2113094
[TBL] [Abstract][Full Text] [Related]
11. Treatment of steroid-resistant and recurrent acute cardiac transplant rejection with a short course of antibody therapy.
Cantarovich M; Latter DA; Loertscher R
Clin Transplant; 1997 Aug; 11(4):316-21. PubMed ID: 9267721
[TBL] [Abstract][Full Text] [Related]
12. Tacrolimus: a superior agent to OKT3 for treating cases of persistent rejection after intrathoracic transplantation.
Meiser BM; Uberfuhr P; Fuchs A; Schulze C; Nollert G; Mair H; Martin S; Pfeiffer M; Reichenspurner H; Kreuzer E; Reichart B
J Heart Lung Transplant; 1997 Aug; 16(8):795-800. PubMed ID: 9286771
[TBL] [Abstract][Full Text] [Related]
13. HLA-DR incompatibility predicts heart transplant rejection independent of immunosuppressive prophylaxis.
Costanzo-Nordin MR; Fisher SG; O'Sullivan EJ; Johnson M; Heroux A; Kao W; Mullen GM; Radvany R; Robinson J
J Heart Lung Transplant; 1993; 12(5):779-89. PubMed ID: 8241215
[TBL] [Abstract][Full Text] [Related]
14. Immunologic sensitization in recipients of left ventricular assist devices.
John R; Lietz K; Schuster M; Naka Y; Rao V; Mancini DM; Rose EA; Smith CR; Oz MC; Edwards NM; Itescu S
J Thorac Cardiovasc Surg; 2003 Mar; 125(3):578-91. PubMed ID: 12658200
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of low-dose OKT3 as cytolytic induction therapy in heart transplantation.
Alonso-Pulpón L; Serrano-Fiz S; Rubio JA; Cavero MA; Silva L; Sánchez-Vegazo I; Burgos R; Montero CG; Maicas C; Kreisler M
J Heart Lung Transplant; 1995; 14(1 Pt 1):136-42. PubMed ID: 7727462
[TBL] [Abstract][Full Text] [Related]
16. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
Herzberg GZ; Rossi AF; Courtney M; Gelb BD
J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
[TBL] [Abstract][Full Text] [Related]
17. OKT3 treatment of cardiac allograft rejection.
Haverty TP; Sanders M; Sheahan M
J Heart Lung Transplant; 1993; 12(4):591-8. PubMed ID: 8369321
[TBL] [Abstract][Full Text] [Related]
18. OKT3 monoclonal antibody given for ten versus fourteen days as immunosuppressive prophylaxis in heart transplantation.
Hegewald MG; O'Connell JB; Renlund DG; Lee HR; Burton NA; Karwande SV; Jones KW; Lassetter JE; Bristow MR
J Heart Transplant; 1989; 8(4):303-9; discussion 309-10. PubMed ID: 2504897
[TBL] [Abstract][Full Text] [Related]
19. Does short-course induction with OKT3 improve outcome after heart transplantation? A randomized trial.
Kobashigawa JA; Stevenson LW; Brownfield E; Moriguchi JD; Kawata N; Hamilton M; Minkely R; Drinkwater D; Laks H
J Heart Lung Transplant; 1993; 12(2):205-8. PubMed ID: 8476892
[TBL] [Abstract][Full Text] [Related]
20. How successful is OKT3 rescue therapy for steroid-resistant acute rejection episodes after heart transplantation?
Wagner FM; Reichenspurner H; Uberfuhr P; Kur F; Kaulbach HG; Meiser BM; Ziegler U; Reichart B
J Heart Lung Transplant; 1994; 13(3):438-42; discussion 442-3. PubMed ID: 8061020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
